FDA Guidance Responding to Unsolicited Request for Off-Label Information…
Recently, the Food and Drug Administration (FDA) released a Guidance for Industry, entitled “Responding to Unsolicited Requests…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
CMS and OMB Announce New Fraud Measures
In 2010, the President announced three goals for cutting improper payments in federal health programs by 2012: reducing overall…
Life Science Businesses Calling for Changes to the Foreign Corrupt…
The Foreign Corrupt Practices Act of 1977 (FCPA), was enacted for the purpose of making it unlawful for certain classes of persons…
AMA CEJA Webinars Offered Clarity to a Confusing Report on CME
Recently, the American Medical Association (AMA) Council on Ethical and Judicial Affairs (CEJA) held it’s two webinars to discuss…
Reductions in Commercial Support for Continuing Medical Education Results…
In light of the recent report from the American Medical Association (AMA) Council on Ethical and Judicial Affairs (CEJA), as well…
CMS Answers Questions on Electronic Health Records
The Centers for Medicare & Medicaid Services (CMS) recently released eight new answers to frequently asked questions (FAQs) to…
FDA the Headache of Developing a Biosimilar Pathway
A recent article from MedPage Today explored a provision in the healthcare reform bill that called on the Food and Drug…
CMS Final Rule on Hospital Meaningful Use and Quality Reporting
The Centers for Medicare & Medicaid Services' final rule updating the hospital outpatient prospective payment system (OPPS)…
Institute of Medicine Report on Essential Benefits
The Patient Protection and Affordable Care Act of 2010 (ACA) was enacted to help uninsured Americans obtain health insurance. As…
CMS Turns Medicare Cuts into Bonus Payments Based on Patient Experience
The Affordable Care Act includes a number of policies to help physicians, hospitals, and other caregivers improve the safety and…